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Forms eternal era, plant, mineral and animal products are used as drugs for the treatment of various diseases. The use of 
medicinal plants for immunomodulation has a long history. The modern medicinal compounds find their leads in natural products. 
Immunomodulation amends the immune system of an individual by prying with its usual functions. Discovery of 
immunomodulators from natural sources has been comprehensively made to modulate the immune system to prevent diseases. 
Hesperidin has been investigated for its potential anti-inflammatory effects. Hesperidin demonstrated analgesic effects in 
experimental animals. The present study is focused on exploring the in silico interaction of hesperidin with some chemokines and 
inflammatory targets. In this study, hesperidin was docked with TNF-α, IL-1β, IL-6, and NOs. Docking studies revealed the 
excellent interaction of hesperidin with these targets. The result of this work provided an insight into the discovery of novel 
molecules for immunomodulation and treatment of inflammatory disorders. Additional studies on hesperidin and associated 
flavonoids are necessary to establish its safety. Hesperidin, can, therefore, can be considered as a candidate for development of an 
immunomodulatory agent. 
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The immune system is a comprehensive network that 
defends the body against invading pathogens. A 
breakdown in the functioning of the immune system 
makes it react in an inappropriate manner
1
. The 
damage to immune system poses a biological burden 
on the body by altering the immunological profile (due 
to allergy or autoimmunity)
2
. Thus, it seems necessary 
to modulate the immune system during the event of 
immunosuppression or immunostimulation. Both these 
classes of synthetic drugs (i.e. immunostimulants and 
immunosuppressants) act by redefining the functions of 
immune cells either by suppressing or stimulating their 
activities
3
. However, these drugs have long-term 
adverse effects like persistent immunosuppression, 
general weakness, alopecia, etc. 
The phenomenon that immune responses are 
modulated to alleviate diseases has existed in many 
forms of traditional medicine beliefs, with plants being 
used in such systems to promote health and to maintain 
the body’s resistance against infections by potentiating 
immunity
4
. Some of these plants are specifically 
stimulatory or suppressive, and normalize or modulate 
pathophysiological processes, and are thereby termed 
‘immunomodulatory’5,6.  
Flavonoids are one of the important phytoconstituents 
having varied biological effects on living systems. 
Owing to their antioxidant effects, flavonoids are 
acknowledged for hepatoprotective, nephroprotective 
and cardio-protective effects
7,8
. Flavonoids also interfere 
with the functioning of pro-inflammatory cytokines and 
chemokines. Hesperidin is citrus flavonoids
9,10
. It is 
acknowledged for prevention of capillary fragility. 
Hesperidin administration (orally) in rats significantly 
allayed irradiation-induced inflammation
11
. The 
modification of lymphocyte composition in the intestinal 
epithelium was observed due hesperidin
12
. Hesperidin 
treatment in mice significantly suppressed levels of 
TNF-α13, IL-1β and IL-614 in mice. There was a decrease 
in the expression of NOs
15
. Based on the above evidence, 
the present study aims to explore in silico interaction of 
hesperidin with interleukins, TNF-α, and NOs. 
 
Materials and methods 
Software  
Python 2.7-language was downloaded from 
www.python.com
16
. Molecular graphics laboratory 
(MGL) tools and AutoDock 4.2
17
 was downloaded  
—————— 
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from www.scripps.edu, Discovery Studio visualizer 
4.1
18
 was downloaded from www.accelerys.com. 
Calculations were performed on Windows 8.0 Operating 
System. 
 
Protein preparation 
The three-dimensional crystalline structures of 4 
targeted proteins were retrieved from the Protein Data 
Bank (http://www.rcsb.org/). The retrieved protein was 
TNF-α (PDB ID: 2AZ5), IL-1β (PDB ID: 2NVH), IL-6 
(PDB ID: 1P9M) and NOs (PDB ID: 1NSI). The 
coordinates of the structures were complexed with 
water molecules, and other atoms which are 
responsible for increased resolution and therefore the 
water molecules and het-atoms were removed using 
discovery studios and saved in. pdb format.  
 
Docking analysis  
Docking studies were performed to analyze 
interactions of hesperidin with immunomodulatory 
targets
19
. The three-dimensional crystalline structures of 
4 proteins were obtained from Protein Data Bank 
(http://www.rcsb.org/). These protein were TNF-α  
(PDB ID: 2AZ5), IL 1β (PDB ID: 2NVH), IL-6  
(PDB ID: 1P9M) and NOs (PDB ID: 5UO1). The 
structurally refined protein .pdb files were converted to. 
pdbqt files using grid module of autodock tools 1.5.6. 
Charges were assigned to the ions to the proteins 
manually wherever necessary. The 2D and 3D chemical 
structures of hesperidin (Molecular formula: C28H34O15; 
Molecular weight 610.57 g/mol) was retrieved 
(http://pubchem.ncbi.nlm.nih.gov/). These .sdf and .mol 
files obtained from PubChem were converted into .pdb 
files using Marwin Sketch (http://www.chemaxon. 
com/marvin/sketch/index.jsp). These .pdb files were 
converted to .pdbqt using ligand preparation module of 
autodock tools 1.5.6. The docking analysis of hesperidin 
was carried out using the Autodock tools (ADT) v1.5.4 
and autodock v 4.2 programs. Hesperidin was docked to 
all the target protein complexes with the molecule 
considered as a rigid body. The search was carried out 
with the Lamarckian Genetic Algorithm; populations of 
100 individuals with a mutation rate of 0.02 have been 
evolved for ten generations. The remaining parameters 
were set as default. The Docked structure was then 
visualised using Discovery Studio 2016 for obtaining the 
binding interactions. 
 
Results 
The four crystal structures of proteins were retrieved 
from protein databank. A docking was performed to 
identify the precise binding sites on various 
immunomodulatory targets. Molecular docking is  
an effective approach that helps to envisage the  
principal ‘binding modes’ of the ligand with  
the ‘protein/receptor/enzyme’ having known ‘three-
dimensional structure’.  
In the present study, docking was carried out on 
active sites of four target proteins 2AZ5, 1ITB, 1P9M 
and 5UO1 with hesperidin. Docking interactions of 
these targets with hesperidin are presented in (Figs. 1-4). 
 
 
Fig. 1 — Molecular docking studies of hesperidin against TNF-α. A - 2D-interactions, B - 3D-interactions 
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The binding energy of hesperidin for TNF-α was −6.96 
kcal/mol, IL-1β −6.64 kcal/mol, IL-6 −7.07 kcal/mol, 
and for NOs −6.83 kcal/mol. Multiple interactions were 
observed with the binding of hesperidin to TNF-α. 
Serine 69 (1.36 Å), leucine 120 (1.46 Å) and Tyrosine 
151 (1.34 Å) from B chain of TNF-α interacted with 
glycone part of hesperidin via hydrogen bonding. π-alkyl 
interaction at Tyrosine 119 (A chain) (1.39 Å) and π- π 
interaction at Tyrosine 119 (B chain) (1.37 Å) were 
observed. In case of IL-1β, glutamic acid 37 (1.45 Å),  
64 (1.21 Å) and lysine 65 (1.55 Å) from (A chain) 
demonstrated hydrogen binding. Methionine 20  
(A chain) (1.52 Å) revealed π-sulphur interaction and 
proline 23 (A chain) (1.52 Å) showed π-alkyl 
interaction. Hesperidin interacted with IL-6 in multiple 
ways. Hydrogen binding at methionine 67 (1.45 Å), 
glutamic acid 172 (1.49 Å), serine 176 (1.23 Å) and 
arginine 179 (B chain) (1.53 Å) was seen. At arginine 
179 (B chain) (1.57 Å) π-alkyl interaction with 
hesperidin aglycone was observed. An unfavorable 
donor-donor interaction at alanine 180 (B chain)  
(1.46 Å) was seen. With respect to NOS, hydrogen 
bonding, π-sigma interaction, π-alkyl interaction,  
carbon-hydrogen bond, and vender Waal interaction 
 
 
Fig. 2 — Molecular docking studies of hesperidin against IL-1β. A - 2D-interactions, B - 3D-interactions 
 
 
 
Fig. 3 — Molecular docking studies of hesperidin against IL-6. A - 2D-interactions, B - 3D-interactions 
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were observed. Hydrogen bonding was seen at aspartic 
acid 476 (1.07 Å) and glutamic acid 710 (A chain)  
(1.23 Å). van der Waal interation was seen at glutamine 
712 (A chain) (1.52 Å). Carbon -hydrogen binding was 
observed at arginine 470 (1.48 Å) and glycine 473  
(A chain) (1.49 Å). π-sigma interaction was observed at 
tyrosine 711 (1.13 Å) whereas π-alkyl interaction was 
seen at proline 713 (A chain) (1.59 Å).  
 
Discussion 
Macrophages play a key function in the production 
of inflammatory cytokines and chemokines  
(e.g. TNF-α and pro-inflammatory interleukins).  
TNF-α, early recognized as an endotoxin-induced 
glycoprotein, play a pivotal role in proliferation, 
migration, differentiation and cell death. The cellular 
events viz. inflammation, infection and malignant 
conditions are observed due to binding of TNF-α 
binding to TNF-α receptors. Over-expression of TNF-α 
is responsible for the progression of pathological 
consequences viz. rheumatoid arthritis, ankylosing 
spondylitis, psoriasis and Crohn's disease
20
. Thus, the 
drugs that act against TNF-α could be effective in the 
management of above mentioned inflammatory 
condition
21
. Many studies proved the inhibitory role of 
hesperidin in decreased expression of TNF-α. 
Hesperidin decreased TNF-α expression on vascular 
cell adhesion molecule-1 which further prevented 
association of monocytes to endothelium
22
. Similar 
effects were observed over other experimental 
models
23
. The docking of hesperidin with TNF-α 
receptor represents a noteworthy interaction which 
could be responsible for its inhibition (as observed 
from previous in vitro studies)
13
.  
Various interactions with inflammatory and immune 
cells are arbitrated by a class of proteins termed as 
interleukins. Interleukins function to support ‘cell 
growth, differentiation, and functional activation’.  
IL-1β and IL-6 are two important interleukins. They 
are produced by macrophages, T-cells and bone 
marrow stromal cells. IL-1β (human leukocyte 
pyrogen/lymphocyte mitogen) is an important mediator 
to evoke an immune response. IL-1β contributes 
towards the progression of pain, inflammation and cell 
apoptosis
24
. Over-expression of IL-1β is responsible for 
the progression of osteoarthritis, rheumatoid arthritis
25
 
and type 2 diabetes
26
. Therefore, the blockade of IL-1β 
and IL-1 receptors is an important strategy to suppress 
inflammation and associated inflammatory disorders. 
The binding site on A chain of IL-1β receptor includes 
some residues viz. 11, 13-15, 20-22, 27, 29-36, 38, 
126-131, 147, and 149
27
. The binding energy of 
interaction between hesperidin and IL-1β receptor as 
observed from docking study was −6.64. Hesperidin 
interacted with some residues of IL-1 receptor next to 
aforementioned active sites which include methionine 20, 
proline 23, glutamic acid 37. In many experiments, 
hesperidin has been studied for its possible inhibitory 
effect on IL-1 receptor and decreased expression of  
IL-1β. In a study, hesperidin administration in rats 
(intoxicated with 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD), a hepatotoxin) caused a decrement in the 
levels of IL-1β28. Many other studies also demonstrated 
 
 
Fig. 4 — Molecular docking studies of hesperidin against NOs. A - 2D-interactions, B - 3D-interactions 
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such effect
29
. Thus, binding of hesperidin with some of 
the crucial residues on IL-1 β receptor may depict one 
of its effects as anti-inflammatory action. 
IL-6 is another proinflammatory cytokine
30
. IL-6 is 
secreted by macrophages and T-cells. It mediates the 
immune response after burns, trauma , and injury. 
Overproduction of IL-6 is associated with progression 
of rheumatoid arthritis
31
 and inflammatory bowel 
disease
32
. IL-6 is a hexameric structure with 
interlocking assembly
33
. The site I interface of the 
structure is surrounded by phenylalanine residue. 
Arginine 179 and lysine 171, by virtue of hydrogen 
bond, confine the specificity. In the present study, the 
interaction of hesperidin with arginine 179 proves 
blockade activity on the IL-6 receptor and thus,  
down-regulation of IL-6 could be predisposed due to 
this interaction. This interaction may also unfold  
anti-inflammatory mechanism of hesperidin in many 
animal studies
34
.  
 
NOs is responsible for the production of nitric oxide 
from the substrate l-arginine
35
. NOs bind calmodulin 
and contain haem. The activity of this enzyme 
increases in ‘response’ to lipopolysaccharide and 
cytokines. NOS finds an important role in numerous 
physiological and pathophysiological conditions, viz. 
regulation of blood pressure, infection, inflammation 
and progression of malignancies
36
. The secretion of 
nitric oxide is increased in cytokine-activated 
macrophages
37
. Nitric oxide, with respect to the 
immune system, regulates the growth, activity , and 
fatality of lymphocytes, macrophages, neutrophils, 
mast cells, antigen presenting cells, natural killer cells 
and antigen-presenting cells
38
. Increased nitrite 
accumulation is observed during arthritis
39
. Thus, a 
decrement in the activity of this enzyme may play a 
vital role in anticipating the inflammation. Some 
natural products have been tested for their potential 
NOS inhibitory activity. Extracts of Acanthopanax 
senticosus
40
, Feijoa sellowiana
41
, and Latycodon 
grandiflorum significantly inhibited the activity of 
NOs
42
. Hesperidin was studied for inhibitory effect on 
lipopolysaccharide-induced over-expression of 
inducible nitric oxide synthase in mouse macrophage. 
Hesperidin in the test dose (10-30 µM) caused a 
significant decrease in nitric oxide production. In 
present docking studies, the interaction of hesperidin 
with tyrosine 711 and glutamine 712 suggest its 
possible interaction with NOs. Altogether, hesperidin 
altogether with other flavonoids (rutin
43
, catechin
44
) 
showed immunomodulatory potential. 
Conclusion 
In the present study, we carried out docking studies 
on hesperidin on various inflammatory and 
immunomodulatory targets, with the purpose to study 
and analyse in silico interaction of former on later. The 
docking scores and analysis of the interactions of 
hesperidin suggest the ability of hesperidin to bind to 
multiple targets involved in inflammation and 
immunomodulation. Hesperidin interacted with various 
chemokines and inflammatory mediators’ viz. TNF-α, 
IL-1β, IL-6, and NOs. With each target, hesperidin 
demonstrated a noteworthy affinity for binding. Findings 
from the present study show that hesperidin may interact 
with several chemokines and inflammatory mediators. 
Further studies on hesperidin and associated flavonoids 
are necessary to develop and establish QSAR and  
QSPR studies that may serve a stepping stone for  
the development of novel, efficient and safe  
immune-modulator. 
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